APA (7th ed.) Citation

Goel, U., Charalampous, C., Kapoor, P., Binder, M., Buadi, F. K., Dingli, D., . . . Rajkumar, S. V. (2024). Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide. Blood Cancer Journal, 14(1), 1-6. https://doi.org/10.1038/s41408-024-01039-1

Chicago Style (17th ed.) Citation

Goel, Utkarsh, et al. "Outcomes of Patients with Multiple Myeloma Refractory to Standard Dose Vs Low Dose Lenalidomide." Blood Cancer Journal 14, no. 1 (2024): 1-6. https://doi.org/10.1038/s41408-024-01039-1.

MLA (8th ed.) Citation

Goel, Utkarsh, et al. "Outcomes of Patients with Multiple Myeloma Refractory to Standard Dose Vs Low Dose Lenalidomide." Blood Cancer Journal, vol. 14, no. 1, 2024, pp. 1-6, https://doi.org/10.1038/s41408-024-01039-1.

Warning: These citations may not always be 100% accurate.
Visit our Citation Styles guide for help on properly citing sources.